TY - JOUR AU - Galiè, N. AU - Hoeper, M. M. AU - Humbert, M. AU - Torbicki, A. AU - Vachiery, J. L. AU - Barbera, J. A. PY - 2009 DA - 2009// TI - Guidelines for the diagnosis and treatment of pul-monary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) JO - Eur Heart J VL - 30 UR - https://doi.org/10.1093/eurheartj/ehp297 DO - 10.1093/eurheartj/ehp297 ID - Galiè2009 ER - TY - JOUR AU - Hartawan, I. AU - Winaya, I. PY - 2011 DA - 2011// TI - Pulmonary hypertension in paediatrics JO - Maj Kedokt Indonesia VL - 58 ID - Hartawan2011 ER - TY - JOUR AU - Prawira, Y. AU - Yanuarso, P. B. PY - 2010 DA - 2010// TI - Sildenafil as a therapeutic choice for pulmonary hypertension after surgery for correction of congenital heart disease in children JO - Sari Pediatri VL - 11 UR - https://doi.org/10.14238/sp11.6.2010.456-462 DO - 10.14238/sp11.6.2010.456-462 ID - Prawira2010 ER - TY - STD TI - Pulmonary Hypertension Association of Indonesia. What Is Pulmonary Hypertension? 2014. Available from: https://www.hipertensiparu.org/apa-itu-hipertensi-paru. [Accessed 6 Nov 2014] UR - https://www.hipertensiparu.org/apa-itu-hipertensi-paru ID - ref4 ER - TY - JOUR AU - Vachiery, J. -. L. AU - Yerly, P. AU - Huez, S. PY - 2012 DA - 2012// TI - How to detect disease progression in pulmonary arterial hypertension JO - Eur Respir Rev VL - 21 UR - https://doi.org/10.1183/09059180.00009011 DO - 10.1183/09059180.00009011 ID - Vachiery2012 ER - TY - JOUR AU - Simonneau, G. AU - Robbins, I. AU - Beghetti, M. AU - Channick, R. N. AU - Delcroix, M. AU - Denton, C. P. PY - 2009 DA - 2009// TI - Updated clinical classification of pulmonary hypertension JO - J Am Coll Cardiol VL - 54 UR - https://doi.org/10.1016/j.jacc.2009.04.012 DO - 10.1016/j.jacc.2009.04.012 ID - Simonneau2009 ER - TY - JOUR AU - Baldi, F. AU - Fuso, L. AU - Arrighi, E. AU - Valente, S. PY - 2014 DA - 2014// TI - Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course JO - Ther Clin Risk Manag VL - 10 ID - Baldi2014 ER - TY - STD TI - World Health Organization. Sildenafil: not for pulmonary hypertension in children. WHO Drug information. 2012;26(4):371. ID - ref8 ER - TY - JOUR AU - Humbert, M. AU - Sitbon, O. AU - Chaouat, A. AU - Bertocchi, M. AU - Habib, G. AU - Gressin, V. PY - 2006 DA - 2006// TI - Pulmonary arterial hypertension in France: results from a national registry JO - Am J Respir Crit Care Med VL - 173 UR - https://doi.org/10.1164/rccm.200510-1668OC DO - 10.1164/rccm.200510-1668OC ID - Humbert2006 ER - TY - STD TI - Thongsri W, Chaikledkaew U, Teerawattananon Y. Systematic review of economic evaluation of drug treatments in pulmonary arterial hypertension (PAH). Mu J Pharm. 2013;(40):45–50. ID - ref10 ER - TY - JOUR AU - Chen, Y. F. AU - Jowett, S. AU - Barton, P. AU - Malottki, K. AU - Hyde, C. AU - Gibbs, J. S. R. PY - 2009 DA - 2009// TI - Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan, and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation JO - Health Technol Assess VL - 13 UR - https://doi.org/10.3310/hta13490 DO - 10.3310/hta13490 ID - Chen2009 ER - TY - JOUR AU - Thongsri, W. AU - Bussabawalai, T. AU - Leelahavarong, P. AU - Wanitkun, S. AU - Durongpisitkul, K. AU - Chaikledkaew, U. PY - 2015 DA - 2015// TI - Cost-utility and budget impact analysis of drug treatments in pulmonary arterial hypertension associated with congenital heart diseases in Thailand JO - Expert Rev Pharmaecon Outcomes Res VL - 10 ID - Thongsri2015 ER - TY - JOUR AU - Galie, N. AU - Ghofrani, H. A. AU - Torbicki, A. AU - Barst, R. J. AU - Rubin, L. J. AU - Badesch, D. PY - 2005 DA - 2005// TI - Sildenafil citrate therapy for pulmonary arterial hypertension JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa050010 DO - 10.1056/NEJMoa050010 ID - Galie2005 ER - TY - JOUR AU - Badesch, D. B. AU - Hill, N. S. AU - Burgess, G. AU - Rubin, L. J. AU - Barst, R. J. AU - Galie, N. PY - 2007 DA - 2007// TI - Sildenafil for pulmonary arterial hypertension associated with connective tissue disease JO - J Rheumatol VL - 34 ID - Badesch2007 ER - TY - JOUR AU - Barst, R. J. AU - McGoon, M. AU - McLaughlin, V. AU - Tapson, V. AU - Rich, S. AU - Rubin, L. PY - 2003 DA - 2003// TI - Beraprost therapy for pulmonary arterial hypertension JO - J Am CollCardiol VL - 41 UR - https://doi.org/10.1016/S0735-1097(03)00463-7 DO - 10.1016/S0735-1097(03)00463-7 ID - Barst2003 ER - TY - BOOK AU - Panichwattana, W. PY - 2010 DA - 2010// TI - Predictors of survival of patients with pulmonary arterial hypertension associated with congenital heart disease PB - Mahidol University CY - Bangkok ID - Panichwattana2010 ER - TY - JOUR AU - Wang, R. AU - Jiang, F. AU - Zheng, Q. AU - Li, C. AU - Peng, X. AU - He, C. PY - 2014 DA - 2014// TI - Efficacy and safety of sildenafil treatment in pulmonary arterial hypertension: a systematic review JO - Respir Med J VL - 108 UR - https://doi.org/10.1016/j.rmed.2014.01.003 DO - 10.1016/j.rmed.2014.01.003 ID - Wang2014 ER - TY - BOOK AU - Reenen, M. V. AU - Oppe, M. PY - 2015 DA - 2015// TI - EQ-5D-3L user guide: basic information on how to use the EQ-5D-3L instrument PB - EuroQol Research Foundation CY - Rotterdam ID - Reenen2015 ER - TY - BOOK AU - Tongsiri, S. PY - 2009 DA - 2009// TI - The Thai population-based preference scores for EQ-5D health states PB - Burden of Disease (BOD) Program, the Health Intervention and Technology Assessment Program (HITAP) and the international Health Policy Program (IHPP) CY - Nonthaburi ID - Tongsiri2009 ER - TY - BOOK PY - 2003 DA - 2003// TI - Health care, cost, quality, and outcomes: ISPOR Book of Terms ID - ref20 ER - TY - JOUR AU - Peacock, A. J. AU - Murphy, N. F. AU - McMurray, J. J. V. AU - Caballero, L. AU - Stewart, S. PY - 2007 DA - 2007// TI - An epidemiological study of pulmonary arterial hypertension JO - Eur Respir J VL - 30 UR - https://doi.org/10.1183/09031936.00092306 DO - 10.1183/09031936.00092306 ID - Peacock2007 ER - TY - JOUR AU - Garin, M. C. AU - Clark, L. AU - Chumney, E. C. AU - Simpson, K. N. AU - Highland, K. B. PY - 2009 DA - 2009// TI - Cost-utility of treatments for pulmonary arterial hypertension: a Markov state transition decision analysis model JO - Clin Drug Invest VL - 29 UR - https://doi.org/10.2165/11317820-000000000-00000 DO - 10.2165/11317820-000000000-00000 ID - Garin2009 ER -